The development of reagents allowing rapid and efficient immunological monitoring of vaccine-induced CD4 T cell responses to human tumor antigens is instrumental for the development of anti-cancer vaccines. Whereas MHC class I fluorescent tetramers incorporating tumor antigen peptides, allowing direct analysis of specific CD8 T cells, are widely used, only few MHC class II tetramers have been generated so far. Here, we generated DRB1*0101 tetramers incorporating an immunodominant peptide from the tumor-specific Research. 
and a summary of the data obtained is reported in Figure 4B . We found a frequent usage of several Vβ segments, including Vβ1, Vβ2 and Vβ3. Vβ1 tetramer + cells were prevalent in the culture of patient N03, representing half of the total population. 
B.
Examples of dot plots for staining of ESO-specific cells with both tetramers at 10 μg/ml and MFI of tetramer staining for all conditions are shown. T cells purified from PBMC from pre-and post-vaccine samples of DR1 + patients were stained ex vivo with DR1/ESO 119-143 tetramers (3 μg/ml) during 2 hrs at 37°C and were then
